7.34
-0.01
(-0.14%)
At close: January 29 at 3:59:58 PM EST
7.31
-0.03
(-0.41%)
Pre-Market: 9:00:27 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | -3.99 | -4.18 | -15.2 | -12.83 |
| Low Estimate | -5.69 | -4.18 | -21.26 | -16.66 |
| High Estimate | -2.29 | -4.18 | -9.13 | -9.01 |
| Year Ago EPS | 21.23 | -5.4 | -11.84 | -15.2 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 261.8M | 270.1M | 965.8M | 1.06B |
| Low Estimate | 261.8M | 270.1M | 965.8M | 1.06B |
| High Estimate | 261.8M | 270.1M | 965.8M | 1.06B |
| Year Ago Sales | 292.87M | 245.09M | 1.16B | 965.8M |
| Sales Growth (year/est) | -10.61% | 10.20% | -16.80% | 9.91% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -5.66 | -5.3 | -3.26 | -2.72 |
| EPS Actual | 21.23 | -5.4 | -2.1 | -5.89 |
| Difference | 26.9 | -0.1 | 1.16 | -3.17 |
| Surprise % | 474.96% | -1.85% | 35.67% | -116.52% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -3.99 | -4.18 | -15.2 | -12.83 |
| 7 Days Ago | -5.69 | -4.18 | -21.26 | -12.83 |
| 30 Days Ago | -5.69 | 0 | -21.26 | -12.83 |
| 60 Days Ago | -2.29 | 0 | -9.13 | -11.89 |
| 90 Days Ago | -2.29 | 0 | -9.13 | -11.89 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NEUE | -118.79% | 22.57% | -28.34% | 15.54% |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Maintains | RBC Capital: Sector Perform to Sector Perform | 12/9/2024 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 3/13/2024 |
| Maintains | Morgan Stanley: Underweight to Underweight | 8/30/2023 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 8/14/2023 |
| Upgrade | Nephron Research: Hold to Buy | 6/30/2023 |
| Downgrade | Barclays: Overweight to Underweight | 6/15/2023 |
Related Tickers
MOH Molina Healthcare, Inc.
304.28
-1.02%
ALHC Alignment Healthcare, Inc.
15.32
+0.66%
CNC Centene Corporation
63.91
-1.25%
CVS.NE CVS Health Corporation
14.14
-0.77%
OSCR Oscar Health, Inc.
16.68
+2.46%
HUM Humana Inc.
294.23
-2.93%
CI The Cigna Group
303.31
+0.16%
ELV Elevance Health, Inc.
400.30
-1.26%
UNH UnitedHealth Group Incorporated
538.10
-0.81%
CVS CVS Health Corporation
56.90
-0.75%